Top broker says Sonic (ASX:SHL) share price is a buy

Here's what this broker thinks of the Sonic share price…

| More on:
Lab worker puts hands in the air and dances around

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sonic Healthcare Limited (ASX: SHL) share price was out of form on Tuesday.

The healthcare company's shares were caught up in the selloff and sank 4% to $39.46.

Is the Sonic share price weakness a buying opportunity?

One leading broker that is likely to see the weakness in the Sonic share price as a buying opportunity is Morgans.

According to a recent note, the broker has an add rating and $45.98 price target on its shares.

Based on the current Sonic share price, this implies potential upside of 16.5% over the next 12 months before dividends.

In addition, Morgans is forecasting a 95 cents per share dividend in FY 2022. If you include this, the total potential return stretches to 19%.

What did the broker say?

Morgans likes Sonic for a number of reasons. One of those is its belief that the company will continue to benefit from COVID testing. While it acknowledges that peak testing may be behind us, it feels the outlook for testing remains strong.

Another reason the broker is bullish on the Sonic share price is its balance sheet. It believes the company has $1.5 billion of balance sheet capacity to use on acquisitions to support its growth.

Morgans commented: "We see COVID-19 testing continuing into the foreseeable future, with growth potential in COVID serology testing. SHL's global base business is increasingly resilient, benefitting from geographical diversity. Strong B/S (gearing 21.6x; A$1.3bn headroom) opening the door to acquisitions, contracts and JVs."

So, although the Sonic share price is smashing the market in 2021 with a 20% gain, Morgans doesn't believe it is too late for investors to get on board. This could make it worth considering, especially after market volatility this week dragged its shares lower.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Woman in celebratory fist move looking at phone
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Broker Notes

These ASX 200 shares could rise 20% to 50%

Looking for big returns? Brokers think these shares could do the job.

Read more »

A young man sits at his desk working on his laptop with a big smile on his face.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

man thinking about whether to invest in bitcoin
Broker Notes

Why Macquarie expects this ASX 200 dividend stock to keep outperforming

Macquarie has tipped this ASX 200 dividend stock to outperform. Let’s find out why.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX 200 shares could rise 20% to 35%

These shares are being tipped to deliver market-beating returns by analysts.

Read more »

Keyboard button with the word sell on it.
Broker Notes

8 ASX All Ords stocks downgraded to sell ratings

Find out which shares are out of favour with the experts.

Read more »

Woman smiling whilst shopping in a clothing store.
Dividend Investing

Why this quality ASX 300 dividend stock is tipped to surge 54%

A leading fund manager forecasts significant outperformance from this quality ASX 300 dividend stock.

Read more »

A group of businesspeople clapping.
Broker Notes

Bell Potter names more of the best ASX 200 stocks to buy in June

These stocks could be best buys this month according to the broker.

Read more »